Literature DB >> 2819869

17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.

T K Gray, T C Flynn, K M Gray, L M Nabell.   

Abstract

We studied the effect of 17 beta-estradiol (E) on the proliferation and alkaline phosphatase activity of cultured UMR106 cells, a clonal osteoblastic cell line. Growth rates were reduced and alkaline phosphatase activity was increased in cells incubated for 2 days in medium containing E (10(-8) M). In contrast, E had no effect on the growth rates or alkaline phosphatase of a human fibroblastic cell line, S90E. The effect of E was not observed with low cell density or at confluence. 1,25-Dihydroxyvitamin D3 antagonized the response to E. Preincubation of the cells with dexamethasone, a potent inducer of differentiation, reversed the effect of E or 1,25-dihydroxyvitamin D3. These results indicate that cellular and/or extracellular factors such as cell density, the phase of the cell cycle, the state of differentiation, and the presence or absence of other steroids influenced the response of UMR106 cells to E. Serum was removed from the culture medium to minimize the effect of the steroids, growth factors, and nutrients present in serum. A striking stimulation of alkaline phosphatase by E occurred with serum-free conditions. This stimulation was biphasic over an E concentration from 10(-12) to 10(-8) M, with the peak response at 10(-10) M. The action of E on UMR106 cells was metabolite-specific, since the isomer 17 alpha-estradiol produced no effect on proliferation rates or alkaline phosphatase activity. The cyclic AMP response to parathyroid hormone (residues 1-34) was not altered by E treatment of these cells. In contrast, dexamethasone exposure did increase the cyclic AMP response to parathyroid hormone. These results demonstrate a direct effect of E on an osteoblastic cell line. They also raise the possibility that similar or identical actions of E occur in cultured normal osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819869      PMCID: PMC299052          DOI: 10.1073/pnas.84.17.6267

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Metabolic properties of hormonally responsive osteogenic sarcoma cells.

Authors:  T J Martin; P M Ingleton; L A Coulton; R A Melick
Journal:  Clin Orthop Relat Res       Date:  1979-05       Impact factor: 4.176

2.  Distinction between alpha-fetoprotein and intracellular estrogen receptors: evidence against the presence of estradiol receptors in rat bone.

Authors:  T L Chen; D Feldman
Journal:  Endocrinology       Date:  1978-01       Impact factor: 4.736

3.  Regulation of 1,25-dihydroxyvitamin D3 receptors in cultured mouse bone cells. Correlation of receptor concentration with the rate of cell division.

Authors:  T L Chen; D Feldman
Journal:  J Biol Chem       Date:  1981-06-10       Impact factor: 5.157

4.  Natural killer cells, bone, and the bone marrow: studies in estrogen-treated mice and in congenitally osteopetrotic (mi/mi) mice.

Authors:  W E Seaman; T D Gindhart; J S Greenspan; M A Blackman; N Talal
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

5.  Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.

Authors:  J C Gallagher; B L Riggs; H F DeLuca
Journal:  J Clin Endocrinol Metab       Date:  1980-12       Impact factor: 5.958

6.  Effect of estradiol benzoate on the proliferation of osteogenic cells in fetal rat fibulae cultured in vitro.

Authors: 
Journal:  Rev Can Biol       Date:  1978-03

7.  Oestrogen binding proteins in bone cell cytosol.

Authors:  H C van Paassen; J Poortman; I H Borgart-Creutzburg; J H Thijssen; S A Duursma
Journal:  Calcif Tissue Res       Date:  1978-08-18

8.  Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis.

Authors:  B L Riggs; H W Wahner; W L Dunn; R B Mazess; K P Offord; L J Melton
Journal:  J Clin Invest       Date:  1981-02       Impact factor: 14.808

9.  Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells.

Authors:  N C Partridge; D Alcorn; V P Michelangeli; B E Kemp; G B Ryan; T J Martin
Journal:  Endocrinology       Date:  1981-01       Impact factor: 4.736

10.  Steroid receptors in osteoblasts.

Authors:  T Yoshioka; B Sato; K Matsumoto; K Ono
Journal:  Clin Orthop Relat Res       Date:  1980-05       Impact factor: 4.176

View more
  38 in total

Review 1.  Skeletal effects of estrogens.

Authors:  G Fiorelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Androgen receptors in osteoblast-like cell lines.

Authors:  E S Orwoll; L Stribrska; E E Ramsey; E J Keenan
Journal:  Calcif Tissue Int       Date:  1991-09       Impact factor: 4.333

3.  The role of non-calcemic analogs of vitamin D in differentiation of cultured rat bone marrow into osteoblast-like cells: age and sex differences.

Authors:  D Somjen; A M Kaye; M Ofer; I Bleiberg
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

4.  Bone blood flow and in vitro proliferation of bone marrow and trabecular bone osteoblast-like cells in ovariectomized rats.

Authors:  D Egrise; D Martin; P Neve; A Vienne; M Verhas; A Schoutens
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

5.  ALP induction by beta-glycerophosphate during the non-mineralization phase in vitro.

Authors:  L Chen; J Schøller; N T Foged
Journal:  J Tongji Med Univ       Date:  1996

6.  Proliferative responses to estradiol, IL-1 alpha and TGF beta by cells expressing alkaline phosphatase in human osteoblast-like cell cultures.

Authors:  D J Rickard; M Gowen; B R MacDonald
Journal:  Calcif Tissue Int       Date:  1993-03       Impact factor: 4.333

7.  Comparison on the effects of three sex hormones on the fetal rat calvarial osteoblasts.

Authors:  L Chen; T Zeng; W Xia; L Ke
Journal:  J Tongji Med Univ       Date:  2000

8.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

9.  Regulation of parathyroid hormone type 1 receptor dynamics, traffic, and signaling by the Na+/H+ exchanger regulatory factor-1 in rat osteosarcoma ROS 17/2.8 cells.

Authors:  David Wheeler; Jose Luis Garrido; Alessandro Bisello; Yung Kyu Kim; Peter A Friedman; Guillermo Romero
Journal:  Mol Endocrinol       Date:  2008-01-17

10.  Effects of estrogen replacement on insulin-like growth factor I concentrations in serum and bone tissue and on interleukin 1 secretion from spleen macrophages in oophorectomized rats.

Authors:  F Sato; Y Ouchi; A Masuyama; T Nakamura; T Hosoi; Y Okamoto; N Sasaki; M Shiraki; H Orimo
Journal:  Calcif Tissue Int       Date:  1993-08       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.